Our projects

Improving tuberculosis detection in childrenThe Decide-TB project is evaluating tools that could help clinicians diagnose TB more reliably in children.

Enhancing uptake of tuberculosis preventive treatmentThe TEST4TPT project seeks to facilitate uptake of TB preventive treatment by enhancing early detection of exposure to TB bacteria.

Closing the diagnostic gap for paediatric tuberculosisThe ACT4KIDS-TB project is assessing whether combining different data sources can enable a clinic-decision-making app that supports...

Extending malaria treatment options for young childrenThe ASAQ-PAC project is developing a child-friendly version of a key antimalarial combination to enable malaria control programmes to...

Protecting the potency of a key tuberculosis drugThe TASP project is evaluating new approaches to extend the lifespan of the critical tuberculosis drug, bedaquiline, by improving detection...

Progressing a multifunctional antimalarialThe RAMP project is advancing the development of a novel antimalarial drug with the potential to both treat the disease and block the transmission...

Treating epilepsy caused by parasite infection  The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...

Reaching those missing out on vaccinationThe REACH-OUT project is developing strategies to ensure that more ‘zero-dose’ children – those missing out entirely on the benefits of vaccines –...

Enhancing clinical research during outbreaksThe ACT-PREP project aims to strengthen capacity for conducting clinical trials in sub-Saharan Africa, with a particular focus on research during...

Improving treatment of cutaneous leishmaniasisThe MAMS4CL project is establishing a clinical trial platform to test improved treatments for cutaneous leishmaniasis, a parasitic disease that...

Advancing modelling capacity to control emerging and re-emerging infectious diseasesThe TIMERA project is strengthening national capacities to use modelling to address the challenges posed...

Factors affecting susceptibility to and severity of mpoxThe DECIPHER-MPOX project is identifying host- and virus-related factors responsible for susceptibility to and the severity of mpox...

Accelerating recovery from choleraThe HUNADIA project is assessing whether a newly developed drug can alleviate the symptoms of cholera, speeding up recovery and shortening or potentially...

Detecting tuberculosis in stool samplesThe STOOL4TB project has been awarded Global Health EDCTP3 funding to complete its EDCTP2-funded study of TB detection in children and people living...

Integrated control of multiple parasitic worm infectionsThe 3SI-CONTROL project is assessing whether it is safe and effective to administer multiple antiparasitic drugs simultaneously and...

Improving treatment of TB meningitisWith Global Health EDCTP3 funding, the EDCTP2-funded INTENSE-TBM project is completing a trial that could radically improve the treatment of tuberculosis...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...